When former port worker Jason Hooker was diagnosed with stage 4 melanoma in January this year, his whānau had just celebrated the news that their 19-year-old son, Mikes, had gone into remission after a seven-year battle with brain and spine cancer.
Ben McGaffney, had to move to Australia to receive funded treatment for stage 3 melanoma that is not funded in New Zealand. Inequitable access to drugs is contributing to hundreds of New Zealanders dying from melanoma each year, and Ben’s story brings home the reason why Melanoma New Zealand continues to lobby for earlier funding and improved patient access to these often lifesaving or life-extending treatments.
Ryman Healthcare is donating $535,000 to charity partner Melanoma New Zealand after a huge year of fundraising around the country. The support included the funds to allow Melanoma New Zealand to buy a Spot Check Van, which has been on the road since February and has...
‘Don’t let a spot become a full stop’. This is the message Melanoma New Zealand and FMG are sharing with rural New Zealanders. With over 50% of rural New Zealand insured with FMG and a strong presence in those communities, FMG has today announced it’s partnering with...